About
Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (15)
View allTotal Trials
15
As Lead Sponsor
14
As Collaborator
1
Total Enrollment
2,176
By Phase
PHASE3: 4PHASE1: 4PHASE2: 4NA: 1PHASE2/PHASE3: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 14ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05279846Lead Sponsor
A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
PHASE3Active, not recruiting
350 participants
Started: May 9, 2022 · Completed: Jan 31, 2025
NCT03244280Lead Sponsor
A Study of the Systemic Absorption of MOB015B
PHASE1Completed
20 participants
Started: Dec 16, 2017 · Completed: Apr 23, 2018
NCT06369675Lead Sponsor
Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design
PHASE1Completed
45 participants
Started: Oct 19, 2017 · Completed: Nov 14, 2017
NCT06369727Lead Sponsor
Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test Design
PHASE1Completed
250 participants
Started: Oct 15, 2017 · Completed: Feb 15, 2018
NCT02859519Lead Sponsor
A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
PHASE3Completed
365 participants
Started: Oct 31, 2016 · Completed: Nov 13, 2019
Locations (1)
Headquarters
Stockholm, Sweden
Map
Loading map...